NR 566 / NR566 Advanced Pharmacology
Care of the Family Midterm Review Quiz
bank | LATEST, Questions and Verified
Answers | Chamberlain College
1.When blood glucose levels are difficult to control in type 2 diabetes some form of insulin may be added to the treatment regimen to control blood glucose and limit complication risks. Which of the following statements is accurate based on research?
A.Premixed insulin analogues are better at lowering HbA1C and have less risk for hypoglycemia.
B.Premixed insulin analogues and the newer premixed insulins are associated with more weight gain than the oral antidiabetic agents.
C.Newer premixed insulins are better at lowering HbA1C and postprandial glucose levels than long-acting insulins.
D.Patients who are not controlled on oral agents and have postprandial hyperglycemia can have neutral protamine Hagedorn insulin added at bedtime.
2.Metformin is a primary choice of drug to treat hyperglycemia in type 2 diabetes because it:
A.Substitutes for insulin usually secreted by the pancreas
B.Decreases glycogenolysis by the liver
C.Increases the release of insulin from beta cells
D.Decreases peripheral glucose utilization
3.Prior to prescribing metformin, the provider should:
A.Draw a serum creatinine to assess renal function
B.Try the patient on insulin
C.Tell the patient to increase iodine intake
D.Have the patient stop taking any sulfonylurea to avoid dangerous drug interactions
4.The action of “gliptins” is different from other antidiabetic agents because they:
A.Have a low risk for hypoglycemia
B.Are not associated with weight gain
C.Close ATP-dependent potassium channels in the beta cell
D.Act on the incretin system to indirectly increase insulin production
5.Sitagliptin has been approved for:
A.Monotherapy in once-daily doses
B.Combination therapy with metformin C.Both 1 and 2
D.Neither 1 nor 2
6.GLP-1 agonists:
A.Directly bind to a receptor in the pancreatic beta cell
B.Have been approved for monotherapy
C.Speed gastric emptying to decrease appetite
D.Can be given orally once daily
7.Avoid concurrent administration of exenatide with which of the following drugs?
A.Digoxin
B.Warfarin
C.Lovastatin
D.All of the above
8.Administration of exenatide is by subcutaneous injection:
A.30 minutes prior to the morning meal
B.60 minutes prior to the morning and evening meal
C.15 minutes after the evening meal
D.60 minutes before each meal daily
9.Potentially fatal granulocytopenia has been associated with treatment of hyperthyroidism with propylthiouracil. Patients should be taught to report:
A.Tinnitus and decreased salivation
B.Fever and sore throat
C.Hypocalcemia and osteoporosis
D.Laryngeal edema and difficulty swallowing
10.Elderly patients who are started on levothyroxine for thyroid replacement should be monitored for:
A.Excessive sedation
B.Tachycardia and angina
C.Weight gain
D.Cold intolerance
11.Which of the following is not an indication that growth hormone supplements should be discontinued?
A.Imaging indication of epiphyseal closure
B.Growth curve increases have plateaued
C.Complaints of mild bone pain
D.Achievement of anticipated height goals
12.Besides osteoporosis, IV bisphosphonates are also indicated for: A.Paget’s Disease
B.Early osteopenia
C.Renal cancer
D.Early closure of cranial sutures
13.What is the role of calcium supplements when patients take bisphosphonates?
A.They must be restricted to allow the medication to work.
B.They must be taken in sufficient amounts to provide foundational elements for bone growth.
C.They must be taken at the same time as the bisphosphonates.
D.They only work with bisphosphonates if daily intake is restricted.
14.Which of the following statements about pancreatic enzymes is true?
A.Dosing may be titrated according to the decrease of steatorrhea.
B.The amount of carbohydrates in the meal drives the amount of enzyme used.
C.The amount of medication used is increased with a cystic fibrosis pulmonary flare.
D.The FDA and Internet-available formulations are bioequivalent.
15.Both men and women experience bone loss with aging. The bones most likely to demonstrate significant loss are:
A.Cortical bones
B.Femoral neck bones
C.Cervical vertebrae
D.Pelvic bones
16. Bisphosphonates treat or prevent osteoporosis by:
A.Inhibiting osteoclastic activity
B.Fostering bone resorption
C.Enhancing calcium uptake in the bone
D.Strengthening the osteoclastic proton pump
17.Prophylactic use of bisphosphonates is recommended for patients with early osteopenia related to long-term use of which of the following drugs?
A.Selective estrogen receptor modulators
B.Aspirin
C.Glucocorticoids
D.Calcium supplements
18.Patients with cystic fibrosis are often prescribed enzyme replacement for pancreatic secretions. Each replacement drug has lipase, protease, and amylase components, but the drug is prescribed in units of:
A.Lipase
B.Protease
Care of the Family Midterm Review Quiz
bank | LATEST, Questions and Verified
Answers | Chamberlain College
1.When blood glucose levels are difficult to control in type 2 diabetes some form of insulin may be added to the treatment regimen to control blood glucose and limit complication risks. Which of the following statements is accurate based on research?
A.Premixed insulin analogues are better at lowering HbA1C and have less risk for hypoglycemia.
B.Premixed insulin analogues and the newer premixed insulins are associated with more weight gain than the oral antidiabetic agents.
C.Newer premixed insulins are better at lowering HbA1C and postprandial glucose levels than long-acting insulins.
D.Patients who are not controlled on oral agents and have postprandial hyperglycemia can have neutral protamine Hagedorn insulin added at bedtime.
2.Metformin is a primary choice of drug to treat hyperglycemia in type 2 diabetes because it:
A.Substitutes for insulin usually secreted by the pancreas
B.Decreases glycogenolysis by the liver
C.Increases the release of insulin from beta cells
D.Decreases peripheral glucose utilization
3.Prior to prescribing metformin, the provider should:
A.Draw a serum creatinine to assess renal function
B.Try the patient on insulin
C.Tell the patient to increase iodine intake
D.Have the patient stop taking any sulfonylurea to avoid dangerous drug interactions
4.The action of “gliptins” is different from other antidiabetic agents because they:
A.Have a low risk for hypoglycemia
B.Are not associated with weight gain
C.Close ATP-dependent potassium channels in the beta cell
D.Act on the incretin system to indirectly increase insulin production
5.Sitagliptin has been approved for:
A.Monotherapy in once-daily doses
B.Combination therapy with metformin C.Both 1 and 2
D.Neither 1 nor 2
6.GLP-1 agonists:
A.Directly bind to a receptor in the pancreatic beta cell
B.Have been approved for monotherapy
C.Speed gastric emptying to decrease appetite
D.Can be given orally once daily
7.Avoid concurrent administration of exenatide with which of the following drugs?
A.Digoxin
B.Warfarin
C.Lovastatin
D.All of the above
8.Administration of exenatide is by subcutaneous injection:
A.30 minutes prior to the morning meal
B.60 minutes prior to the morning and evening meal
C.15 minutes after the evening meal
D.60 minutes before each meal daily
9.Potentially fatal granulocytopenia has been associated with treatment of hyperthyroidism with propylthiouracil. Patients should be taught to report:
A.Tinnitus and decreased salivation
B.Fever and sore throat
C.Hypocalcemia and osteoporosis
D.Laryngeal edema and difficulty swallowing
10.Elderly patients who are started on levothyroxine for thyroid replacement should be monitored for:
A.Excessive sedation
B.Tachycardia and angina
C.Weight gain
D.Cold intolerance
11.Which of the following is not an indication that growth hormone supplements should be discontinued?
A.Imaging indication of epiphyseal closure
B.Growth curve increases have plateaued
C.Complaints of mild bone pain
D.Achievement of anticipated height goals
12.Besides osteoporosis, IV bisphosphonates are also indicated for: A.Paget’s Disease
B.Early osteopenia
C.Renal cancer
D.Early closure of cranial sutures
13.What is the role of calcium supplements when patients take bisphosphonates?
A.They must be restricted to allow the medication to work.
B.They must be taken in sufficient amounts to provide foundational elements for bone growth.
C.They must be taken at the same time as the bisphosphonates.
D.They only work with bisphosphonates if daily intake is restricted.
14.Which of the following statements about pancreatic enzymes is true?
A.Dosing may be titrated according to the decrease of steatorrhea.
B.The amount of carbohydrates in the meal drives the amount of enzyme used.
C.The amount of medication used is increased with a cystic fibrosis pulmonary flare.
D.The FDA and Internet-available formulations are bioequivalent.
15.Both men and women experience bone loss with aging. The bones most likely to demonstrate significant loss are:
A.Cortical bones
B.Femoral neck bones
C.Cervical vertebrae
D.Pelvic bones
16. Bisphosphonates treat or prevent osteoporosis by:
A.Inhibiting osteoclastic activity
B.Fostering bone resorption
C.Enhancing calcium uptake in the bone
D.Strengthening the osteoclastic proton pump
17.Prophylactic use of bisphosphonates is recommended for patients with early osteopenia related to long-term use of which of the following drugs?
A.Selective estrogen receptor modulators
B.Aspirin
C.Glucocorticoids
D.Calcium supplements
18.Patients with cystic fibrosis are often prescribed enzyme replacement for pancreatic secretions. Each replacement drug has lipase, protease, and amylase components, but the drug is prescribed in units of:
A.Lipase
B.Protease
